(Q44346048)

2 December 2017

title

Proton magnetic resonance imaging and spectroscopy identify metabolic changes in the striatum in the MPTP feline model of parkinsonism (English)

1 reference

2 December 2017

1 reference

1 reference

3

Mark A Smith

1 reference

2 December 2017

Michael Podell

1

1 reference

2 December 2017

Maria Hadjiconstantinou

series ordinal

2

1 reference

2 December 2017

Norton H Neff

series ordinal

4

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

2 December 2017

published in

Experimental Neurology

1 reference

2 December 2017

volume

179

1 reference

2 December 2017

issue

2

1 reference

2 December 2017

page(s)

159-166

1 reference

Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

Proton MRS in neurological disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

The early diagnosis of Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

Morphological and functional imaging studies on the diagnosis and progression of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

Combined PET/MRS brain studies show dynamic and long-term physiological changes in a primate model of Parkinson disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

Free radicals and the pathobiology of brain dopamine systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

Neuronal laterality in Parkinson's disease with unilateral symptom by in vivo 1H magnetic resonance spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

Positron emission tomography (PET) in the study of dopamine receptors in the primate brain: evaluation of a kinetic model using 11C-N-methyl-spiperone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: a proton magnetic resonance spectroscopy study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

Imaging the rat brain on a 1.5 T clinical MR-scanner.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases acetylcholine and decreases dopamine in mouse striatum: both responses are blocked by anticholinergic drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

Magnetic resonance imaging of neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

Pretreatment with nimodipine prevents MPTP-induced neurotoxicity at the nigral, but not at the striatal level in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

MRI detects acute degeneration of the nigrostriatal dopamine system after MPTP exposure in hemiparkinsonian monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

Progressive encephalopathy associated with CD4/CD8 inversion in adult FIV-infected cats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and free radicals in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

Neurotoxic effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the cat. Tyrosine hydroxylase immunohistochemistry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

Neurochemical evaluation of the striatum in symptomatic and recovered MPTP-treated cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

Production of a Parkinson-like syndrome in the cat with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior, histology, and biochemistry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

Mechanism of the neurotoxicity of 1-methyl-4-phenylpyridinium (MPP+), the toxic bioactivation product of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

Increased iron in the substantia nigra compacta of the MPTP-lesioned hemiparkinsonian African green monkey: evidence from proton microprobe elemental microanalysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900015-8

10.1016/S0014-4886(02)00015-8

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference